methylamine has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Gao, H; Jia, J; Lin, Q; Lin, X; Wei, T; Xia, H; Yan, Z; Ye, X; Zhao, L | 1 |
| Jalkanen, S; Kari, S; Madanat, R; Marti, L; Sariola, H; Stolen, CM; Yegutkin, GG; Zorzano, A | 1 |
2 other study(ies) available for methylamine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice.
Topics: Aconitic Acid; Acyl Coenzyme A; Allantoin; Amidohydrolases; Animals; Biomarkers; Diabetic Nephropathies; Discriminant Analysis; Fatty Acids; Guanosine Triphosphate; Kidney; Male; Metabolomics; Methylamines; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Nuclear Magnetic Resonance, Biomolecular; Principal Component Analysis; Receptors, Leptin | 2015 |
Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Topics: Amine Oxidase (Copper-Containing); Animals; Arteriosclerosis; Blood Glucose; Cell Adhesion Molecules; Diabetic Angiopathies; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Hypertension; Hypertrophy; Insulin; Kidney; Methylamines; Mice; Mice, Transgenic; Models, Biological; Molecular Mimicry; Obesity | 2004 |